The PPAR-α agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a/β-catenin and activating PGC-1α: Involvement of network pharmacology and molecular docking

Citation:
El Tabaa, M. M., H. Faheem, M. S. Elballal, E. Rashad, M. Mohsen, and M. Mohammed, "The PPAR-α agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a/β-catenin and activating PGC-1α: Involvement of network pharmacology and molecular docking", European Journal of Pharmacology, vol. 991, 2025.

Start Page:

177306

Abstract:

n/a

Notes:

n/a

Tourism